Your browser doesn't support javascript.
loading
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
Hoffmann, Lone; Mortensen, Hanna; Shamshad, Muhammad; Berbee, Maaike; Bizzocchi, Nicola; Bütof, Rebecca; Canters, Richard; Defraene, Gilles; Ehmsen, Mai Lykkegaard; Fiorini, Francesca; Haustermans, Karin; Hulley, Ryan; Korevaar, Erik W; Clarke, Matthew; Makocki, Sebastian; Muijs, Christina T; Murray, Luke; Nicholas, Owen; Nordsmark, Marianne; Radhakrishna, Ganesh; Thomas, Melissa; Troost, Esther G C; Vilches-Freixas, Gloria; Visser, Sabine; Weber, Damien C; Møller, Ditte Sloth.
Afiliação
  • Hoffmann L; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark. Electronic address: Lone.Hoffmann@aarhus.rm.dk.
  • Mortensen H; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark.
  • Shamshad M; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark.
  • Berbee M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands.
  • Bizzocchi N; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
  • Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit
  • Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands.
  • Defraene G; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium.
  • Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Denmark.
  • Fiorini F; Rutherford Cancer Centre, Shinfield, Reading, UK.
  • Haustermans K; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium.
  • Hulley R; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
  • Korevaar EW; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Clarke M; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
  • Makocki S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit
  • Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Murray L; Rutherford Cancer Centre, Shinfield, Reading, UK.
  • Nicholas O; South West Wales Cancer Centre, Swansea University Board and Swansea University Medical School, UK.
  • Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark.
  • Radhakrishna G; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
  • Thomas M; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium.
  • Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit
  • Vilches-Freixas G; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands.
  • Visser S; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland.
  • Møller DS; Department of Medical Physics, Aarhus University Hospital, Denmark; Dept. of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.
Radiother Oncol ; 172: 32-41, 2022 07.
Article em En | MEDLINE | ID: mdl-35513132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Radioterapia de Intensidade Modulada / Terapia com Prótons Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Radioterapia de Intensidade Modulada / Terapia com Prótons Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2022 Tipo de documento: Article